U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07845630) titled 'A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the Body' on Sept. 23.
Brief Summary: The main objective of this trial is to establish the bioequivalence of two different formulations of vicadrostat / empagliflozin in healthy male and female trial participants following oral administration.
Study Start Date: Oct. 14
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Vicadrostat
Vicadrostat
DRUG: Empagliflozin
Empagliflozin
DRUG: Vicadrostat + empagliflozin
Vicadrostat + empagliflozin combined
Recruitment Status: NOT_YET_RECRUITING
S...